Table 4.
Risk factors | Univariable analysis | Multivariable analysis | ||
Hazard ratio (95% CI) | p Value | Hazard ratio (95% CI) | p Value | |
YK administration (not YKCH) | 2.84 (1.37 to 5.87) | 0.005 | 3.09 (1.41 to 6.80) | 0.005 |
LPIDs co-administration | 2.88 (1.89 to 4.38) | <0.001 | 2.74 (1.75 to 4.29) | <0.001 |
Hypoalbuminaemia† | 2.95 (1.94 to 4.49) | <0.001 | 2.15 (1.36 to 3.38) | 0.001 |
Fully-dosed amount | 1.64 (1.05 to 2.55) | 0.029 | 1.60 (1.01 to 2.55) | 0.048 |
Female | 1.36 (0.89 to 2.06) | 0.153 | 1.32 (0.85 to 2.03) | 0.215 |
Age | 1.00 (0.99 to 1.02) | 0.537 | 1.00 (0.99 to 1.02) | 0.673 |
Serum potassium† (≥4.1 mEq/L) | 0.36 (0.24 to 0.54) | <0.001 | 0.45 (0.29 to 0.70) | <0.001 |
*Cox proportional hazard model was used.
†Determined at baseline.
LPIDs, lower potassium-inducing drugs; YK, Yokukansan; YKCH, Yokukansan-ka-chimpihange.